UBS O'Connor’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

UBS O'Connor’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-341,950	Closed	-$47.9M	–	677
2020 Q3	$47.9M	Buy	+341,950	New	+$41.7M	1.22%	17
2020 Q2	–	Sell	-65,302	Closed	-$1.86M	–	466
2020 Q1	$1.86M	Sell	65,302 -56,204	-46%	-$1.46M	0.04%	186
2019 Q4	$3.04M	Sell	121,506 -5,677	-4%	-$136K	0.09%	172
2019 Q3	$2.22M	Buy	+127,183	New	+$3.85M	0.06%	164

UBS O'Connor's LVGO Position: Q4 2020 in Review

UBS O'Connor sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 341,950 shares — an estimated $47.9M sold.

UBS O'Connor first reported a position in LVGO in Q3 2019 and held it in 4 quarters. The position peaked at $47.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

UBS O'Connor reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
UBS O'Connor sold 341,950 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $47.9M.
UBS O'Connor first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
UBS O'Connor's Livongo Health, Inc. Common Stock position peaked at $47.9M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on UBS O'Connor's 13F filing for Q4 2020, filed 17 Feb 2021.